New FDA Approvals

Tricuspid Valve Replacement System, Afami-Cel for Synovial Sarcoma, Pulsed Field Ablation for Atrial Fibrillation, Shorter Turnaround Time for Axi-cel, AI Algorithm for Cervical Cancer, Trastuzumab Deruxtecan for Solid Tumors


Listen Later

ChatGPT4 in medical writing and editing at learnAMAstyle.com

Nascentmc.com for medical writing assistance for your company.

Visit nascentmc.com/podcast for full show notes

  • Tricuspid Valve Replacement System for Tricuspid Regurgitation The FDA approved the Evoque tricuspid valve replacement system, a first in the U.S. for a transcatheter tricuspid device, after the TRISCEND II trial showed significant improvements in TR grade and patient symptoms. TR, where the heart's valve does not close properly causing blood backflow, can now be treated with this device, which also received CE Mark approval in Europe and is produced by Edwards Lifesciences.
  • Afami-Cel for Synovial Sarcoma The FDA is prioritizing the review of afamitresgene autoleucel (afami-cel) for advanced synovial sarcoma, based on positive results from the SPEARHEAD-1 trial showing a 39% response rate and increased survival rates. Afami-cel targets MAGE-A4 in synovial sarcoma, a rare soft tissue sarcoma, offering a new treatment option for this aggressive disease. It's manufactured by Adaptimmune Therapeutics with a decision expected by August 4, 2024. 
  • Pulsed Field Ablation for Atrial Fibrillation Boston Scientific's FARAPULSE PFA System has been FDA approved for treating intermittent atrial fibrillation, offering a non-thermal, tissue-selective ablation alternative with proven safety and efficacy. The approval was based on the ADVENT study and real-world data, highlighting shorter ablation times and no severe side effects. Boston Scientific plans an immediate U.S. launch.
  • Shorter Turnaround Time for Axi-cel The FDA approved a manufacturing process change for axi-cel (Yescarta), reducing delivery time from 16 to 14 days, which is a CD19-directed CAR T-cell therapy for certain lymphomas. This change, granted to Kite, a Gilead Sciences subsidiary, aims to improve treatment accessibility by offering faster delivery of this personalized therapy.
  • AI Algorithm for Cervical Cancer Screening Hologic's Genius™ Digital Diagnostics System with the Genius™ Cervical AI algorithm has been FDA approved, introducing the first digital cytology platform integrating AI for cervical cancer screening. This system digitizes traditional Pap test slides, applying AI to enhance detection of pre-cancerous and cancerous cells, improving sensitivity and enabling remote case review. It will be available in the U.S. in early 2024.
  • Trastuzumab Deruxtecan for Solid Tumors The FDA granted priority review to trastuzumab deruxtecan for treating unresectable or metastatic HER2-positive solid tumors, potentially marking it as the first HER2-directed, tumor-agnostic therapy. Based on the DESTINY-PanTumor02 study, showing promising survival outcomes, a decision is expected in the second quarter of 2024. The drug is developed by AstraZeneca and Daiichi Sankyo.

 

...more
View all episodesView all episodes
Download on the App Store

New FDA ApprovalsBy Emma Hitt Nichols, PhD

  • 5
  • 5
  • 5
  • 5
  • 5

5

4 ratings


More shows like New FDA Approvals

View all
NEI Podcast by Neuroscience Education Institute

NEI Podcast

129 Listeners

NEJM This Week by NEJM Group

NEJM This Week

325 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

493 Listeners

STEM-Talk by Dawn Kernagis and Ken Ford

STEM-Talk

652 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,332 Listeners

JAMA Medical News by JAMA Network

JAMA Medical News

90 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

122 Listeners

AHLA's Speaking of Health Law by American Health Law Association

AHLA's Speaking of Health Law

28 Listeners

Real Life Pharmacology - Pharmacology Education for Health Care Professionals by Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist

Real Life Pharmacology - Pharmacology Education for Health Care Professionals

716 Listeners

The Readout Loud by STAT

The Readout Loud

318 Listeners

The Carlat Psychiatry Podcast by Pocket Psychiatry: A Carlat Podcast

The Carlat Psychiatry Podcast

559 Listeners

Business Of Biotech by Ben Comer

Business Of Biotech

88 Listeners

CEimpact Podcast by CEimpact

CEimpact Podcast

17 Listeners

Truth, Lies & Alzheimer's by Lisa Skinner

Truth, Lies & Alzheimer's

15 Listeners

Conversations in Drug Development by Boyds

Conversations in Drug Development

3 Listeners